3-BUTYL-3-ETHYL-2,3,4,5-TETRAHYDRO-7-METHOXY-1,1-DIOXIDO-5-PHENYL-1,4-BENZOTHIAZEPIN-8-YL 1,1,1-TRIFLUOROMETHANESULFONATE, (3R,5R)-
UNII EDP4Z8MWU3
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl 1,1,1-trifluoromethanesulfonate, (3r,5r)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EDP4Z8MWU3.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1345983-39-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H28F3NO6S2 LHAYZDULSNURMY-FGZHOGPDSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-butyl-3-ethyl-2,3,4,5-tetrahydro-7-methoxy-1,1-dioxido-5-phenyl-1,4-benzothiazepin-8-yl 1,1,1-trifluoromethanesulfonate, (3r,5r)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.